 Shares of ENOB stock are taking off on Monday after Enochain Biosciences received FDA acceptance for its vital HIV treatment. The post ENOB Stock: The HIV Treatment News That Has Enochain Biosciences Skyrocketing Today appeared first on InvestorPlace. 